Clinical Trials Directory

Trials / Completed

CompletedNCT02918942

Tympanoseal (Tympanic Membrane Device) Clinical Study

Status
Completed
Phase
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Grace Medical, Inc. · Industry
Sex
All
Age
2 Years
Healthy volunteers
Not accepted

Summary

The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.

Detailed description

This study will provide data on the safety and the ability of sodium/calcium alginate gels to act as a scaffold capable of occluding a tympanic membrane perforation over the duration of complete healing. Tympanoseal could be used in cases where cartilage or fat graft tympanoplasty would be indicated.

Conditions

Interventions

TypeNameDescription
DEVICETympanosealAll subjects will receive the Tympanoseal device that will be placed during a surgical procedure.

Timeline

Start date
2016-10-04
Primary completion
2021-09-30
Completion
2021-09-30
First posted
2016-09-29
Last updated
2024-10-15
Results posted
2024-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02918942. Inclusion in this directory is not an endorsement.